Literature DB >> 19747576

Functional properties and epitope characteristics of T-cells recognizing natural HIV-1 variants.

U Malhotra1, J Nolin, H Horton, F Li, L Corey, J I Mullins, M J McElrath.   

Abstract

To understand how broad recognition of HIV-1 variants may be achieved we examined T-cell reactivity in newly infected persons as well as vaccine recipients to a broad spectrum of potential T-cell epitope (PTE) variants containing conservative, semi-conservative and non-conservative amino acid substitutions. Among early infected persons T-cells recognized epitope variants with one substitution at a significantly higher frequency versus those with two (P=0.0098) and three (P=0.0125) substitutions. Furthermore T-cells recognized variants containing conservative substitutions at a higher frequency versus those containing semi-conservative (P=0.0029) and non-conservative (P<0.0001) substitutions. Similar effects were observed on recognition of variants by vaccine-induced T-cells. Moreover even when variants were recognized, the IFN-gamma and granzyme B responses as well as T-cell proliferation were of lower magnitude. Finally, we show that epitope distribution is strongly influenced by both processing preferences and amino acid entropy. We conclude that induction of broad immunity is likely to require immunogen sequences that encompass multiple variants. However, cost-effective design of peptide and sequence based vaccine immunogens that provide maximal coverage of circulating sequences may be achieved through emphasis on virus domains likely to be T-cell targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747576      PMCID: PMC2845637          DOI: 10.1016/j.vaccine.2009.08.093

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  57 in total

Review 1.  The proteasome.

Authors:  M Bochtler; L Ditzel; M Groll; C Hartmann; R Huber
Journal:  Annu Rev Biophys Biomol Struct       Date:  1999

2.  The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage.

Authors:  Morten Nielsen; Claus Lundegaard; Ole Lund; Can Keşmir
Journal:  Immunogenetics       Date:  2005-03-03       Impact factor: 2.846

3.  Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the "immunoproteasome".

Authors:  C Cardozo; R A Kohanski
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

4.  Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation.

Authors:  Fusheng Li; Uma Malhotra; Peter B Gilbert; Natalie R Hawkins; Ann C Duerr; Juliana M McElrath; Lawrence Corey; Steven G Self
Journal:  Vaccine       Date:  2006-06-27       Impact factor: 3.641

Review 5.  Evolutionary dynamics of HIV-1 and the control of AIDS.

Authors:  J I Mullins; M A Jensen
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

6.  Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents.

Authors:  Paul M Coplan; Swati B Gupta; Sheri A Dubey; Punnee Pitisuttithum; Alex Nikas; Bernard Mbewe; Efthyia Vardas; Mauro Schechter; Esper G Kallas; Dan C Freed; Tong-Ming Fu; Christopher T Mast; Pilaipan Puthavathana; James Kublin; Kelly Brown Collins; John Chisi; Richard Pendame; Scott J Thaler; Glenda Gray; James Mcintyre; Walter L Straus; Jon H Condra; Devan V Mehrotra; Harry A Guess; Emilio A Emini; John W Shiver
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

7.  Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.

Authors:  F Buseyne; M L Chaix; B Fleury; O Manigart; O Manigard; M Burgard; S Blanche; C Rouzioux; Y Rivière
Journal:  Virology       Date:  1998-10-25       Impact factor: 3.616

8.  Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa.

Authors:  L Dorrell; T Dong; G S Ogg; S Lister; S McAdam; T Rostron; C Conlon; A J McMichael; S L Rowland-Jones
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.

Authors:  S E Wilson; S L Pedersen; J C Kunich; V L Wilkins; D L Mann; G P Mazzara; J Tartaglia; C L Celum; H W Sheppard
Journal:  AIDS Res Hum Retroviruses       Date:  1998-07-20       Impact factor: 2.205

10.  Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais.

Authors:  J A Lynch; M deSouza; M D Robb; L Markowitz; S Nitayaphan; C V Sapan; D L Mann; D L Birx; J H Cox
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

View more
  5 in total

1.  Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

Authors:  Glenda E Gray; Mary Allen; Zoe Moodie; Gavin Churchyard; Linda-Gail Bekker; Maphoshane Nchabeleng; Koleka Mlisana; Barbara Metch; Guy de Bruyn; Mary H Latka; Surita Roux; Matsontso Mathebula; Nivashnee Naicker; Constance Ducar; Donald K Carter; Adrien Puren; Niles Eaton; M Julie McElrath; Michael Robertson; Lawrence Corey; James G Kublin
Journal:  Lancet Infect Dis       Date:  2011-05-11       Impact factor: 25.071

2.  Cross-Reactive CD8 T-Cell Responses Elicited by Adenovirus Type 5-Based HIV-1 Vaccines Contributed to Early Viral Evolution in Vaccine Recipients Who Became Infected.

Authors:  Sushma Boppana; Andrew Fiore-Gartland; Anju Bansal; Paul Goepfert
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

3.  Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion.

Authors:  Carina L Perez; Jeffrey M Milush; Marcus Buggert; Emily M Eriksson; Mette V Larsen; Teri Liegler; Wendy Hartogensis; Peter Bacchetti; Ole Lund; Frederick M Hecht; Douglas F Nixon; Annika C Karlsson
Journal:  AIDS Res Hum Retroviruses       Date:  2013-01-08       Impact factor: 2.205

4.  Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes.

Authors:  Coral-Ann M Almeida; Corine Bronke; Steven G Roberts; Elizabeth McKinnon; Niamh M Keane; Abha Chopra; Carl Kadie; Jonathan Carlson; David W Haas; Sharon A Riddler; Richard Haubrich; David Heckerman; Simon Mallal; Mina John
Journal:  J Immunol       Date:  2011-08-05       Impact factor: 5.422

5.  Increased sequence coverage through combined targeting of variant and conserved epitopes correlates with control of HIV replication.

Authors:  Justine Sunshine; Moon Kim; Jonathan M Carlson; David Heckerman; Julie Czartoski; Stephen A Migueles; Janine Maenza; M Juliana McElrath; James I Mullins; Nicole Frahm
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.